Report overview
Urticaria is commonly known as rubella. It is a localized edema response due to dilation of the skin and mucosal small blood vessels and increased permeability. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of the disease is delayed for several days to several months. More common in clinically.
This report aims to provide a comprehensive presentation of the global market for Urticaria Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urticaria Drug. This report contains market size and forecasts of Urticaria Drug in global, including the following market information:
Global Urticaria Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Urticaria Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Urticaria Drug companies in 2023 (%)
The global Urticaria Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Acute Urticaria Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Urticaria Drug include Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech and Xolair, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urticaria Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urticaria Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, by Type, 2023 (%)
Acute Urticaria
Chronic Urticaria
Global Urticaria Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Urticaria Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Urticaria Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urticaria Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Urticaria Drug revenues share in global market, 2023 (%)
Key companies Urticaria Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Urticaria Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson Services
Amneal Pharmaceuticals
Pfizer
Taro Pharmaceutical Industries Novartis AG
Akorn
Teva Pharmaceutical Industries
Genentech
Xolair
Outline of Major Chapters:
Chapter 1: Introduces the definition of Urticaria Drug, market overview.
Chapter 2: Global Urticaria Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Urticaria Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Urticaria Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
